Enhance MD vs CoreAgeRx: Pricing and Compound Options Compared
Enhance MD vs CoreAgeRx centers on pricing approach and compound availability. Early verdict: if lowest first-month cost for compounded semaglutide or tirzepatide matters, Enhance MD leads; if predictable monthly billing without membership is essential, CoreAgeRx leads.
See Enhance MD pricing and options
How they price GLP-1 compounds
Both providers emphasize stable pricing, but the mechanics differ. Enhance MD advertises introductory first-month rates: semaglutide from $49 and tirzepatide from $99, followed by a flat-rate ongoing charge that the company says stays the same at every dose. CoreAgeRx promotes “Same Price. Every Month.” with semaglutide at $79 per month and tirzepatide at $129 per month and no membership fee.
View CoreAgeRx monthly pricing
Direct comparison: 6 key differences
The most distinctive differences between Enhance MD and CoreAgeRx are starting price for the first month, ongoing billing model clarity, availability of two compounds on one platform, published monthly rates, clinician review statements, and regulatory notes about compounded medications.
| Criteria | Enhance MD | CoreAgeRx |
|---|---|---|
| Semaglutide starting price | From $49 first month | $79 per month |
| Tirzepatide starting price | From $99 first month | $129 per month |
| Ongoing pricing model | Flat-rate pricing, same price at every dose after intro | Same price every month, no membership fee |
| Compound options | Both semaglutide and tirzepatide available on one platform | Semaglutide and tirzepatide offered with specific monthly rates |
| Clinical review | Treatment available only when a licensed clinician determines it is medically appropriate | Treatment available only when a licensed clinician determines it is medically appropriate |
| Regulatory note | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality | Medication-specific approval status must be confirmed; branded and compounded products are not interchangeable |
Pricing and predictability
Enhance MD emphasizes low entry cost with semaglutide from $49 and tirzepatide from $99 for the first month, and a flat-rate claim that the price stays the same at every dose so there is no escalation during titration. CoreAgeRx emphasizes steady monthly billing with semaglutide at $79 per month and tirzepatide at $129 per month and explicitly states no membership fee or price hikes.
Compound availability and platform choice
Enhance MD is presented as a multi-option platform offering both semaglutide and tirzepatide in compounded form, which the source highlights as useful for patients choosing between compounds. CoreAgeRx also lists both compounds with set monthly prices and notes dose caps: semaglutide up to 1.0 mg and tirzepatide up to 7.5 mg as captured on the landing content.
Clinical oversight and regulatory cautions
Both sources state that treatment is provided only when a licensed clinician determines it is medically appropriate. Enhance MD explicitly notes that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. CoreAgeRx reminds readers that medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable.
Side-by-side strengths
Enhance MD: lowest advertised first-month prices for compounded semaglutide and tirzepatide, flat-rate dose pricing, and a reported patient volume above 10,000. CoreAgeRx: emphasis on consistent monthly billing without membership fees and published per-month prices for each compound.
Final take: Enhance MD vs CoreAgeRx
Use the primary keyword: Enhance MD vs CoreAgeRx. Choose Enhance MD if your priority is the lowest first-month cost for compounded semaglutide or tirzepatide and a platform offering both compounds with flat-rate dosing claims. Choose CoreAgeRx if you prefer a clearly stated same-month price model with no membership fee and monthly rates published on the landing content.
Remember that both providers require clinician review before treatment and include regulatory notes about compounded medications and approval status.
Choose Enhance MD if you want the lowest advertised first-month compound pricing and a single platform for semaglutide and tirzepatide. Choose CoreAgeRx if you want published same-price-every-month billing with no membership fee.